Report : Asia Pacific Diet Pills Market Forecast to 2028 – Regional Analysis – By Product Type (Prescription, Over the Counter Drugs, and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Children and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)
Adult Segment to Dominate APAC Diet Pills Market During 2021–2028
According to a new market research study on “Asian-Pacific Diet Pills Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Application, Age Group, Distribution Channel, and Country” is expected to reach US$ 480.53 million by 2028 from US$ 231.15 million in 2021. The market is estimated to grow at a CAGR of 11.0% from 2021 to 2028. The report provides trends prevailing in the APAC diet pills market along with the drivers and restraints pertaining to the market growth. Growth in self-directed care and increasing problem of obesity are the major factor driving the growth of the APAC diet pills market. However, difficult regulatory environment hinders the growth of APAC diet pills market.
The APAC diet pills market is segmented based on product type, application, age group, distribution channel and country. Based on product type, the APAC diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the APAC diet pills market in 2020. Based on application, the APAC diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment dominated the APAC diet pills market in 2020. Based on age group, APAC diet pills market is segmented into adults, and teenagers. The adults segment dominated the APAC diet pills market in 2020. Based on distribution channel, APAC diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug Stores. The hospital pharmacies segment dominated the APAC diet pills market in 2020. Based on country, the APAC diet pills market is segmented into China, Japan, India, South Korea, Australia, and Rest of APAC. The China segment dominated the APAC diet pills market in 2020.
Novo Nordisk A/S; GlaxoSmithKline plc; Lovate Health Sciences International Inc.; TEVA Pharmaceutical Industries LTD; and Chong’s Health Care are among the leading companies in the APAC Diet Pills market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, TEVA PHARMACEUTICAL INDUSTRIES LTD ceased the distribution of weight loss drug Belviq in Israel amid cancer scare. The company filed a voluntary request to withdraw the drug following a request from the FDA, due to clinical trial findings that showed the drug might increase risk of cancer.. Furthermore, company started recalling the drug in collaboration with the Israeli Ministry of Health.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com